The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. ARS Pharmaceuticals Inc’s current trading price is -22.75% away from its 52-week high, while its distance from the 52-week low is 46.00%. The stock’s price range for this period has been between $10.00 and $18.90 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 2.16 million for the day, a number notably higher than the average daily volume of 1.5 million over the last three months.
At present, ARS Pharmaceuticals Inc (SPRY) has a stock price of $14.6. In the previous session, the stock saw a rise, peaking at $40.0 after an opening price of $14.6. The day’s lowest price was $25.0, and it closed at $13.79.
ARS Pharmaceuticals Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $18.90 on 06/27/25 and the lowest value was $10.00 on 03/04/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
ARS Pharmaceuticals Inc (SPRY) has experienced a quarterly rise of 1.88% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.44B and boasts a workforce of 160 employees.
ARS Pharmaceuticals Inc: What Analysts Are Saying
As of right now, 5 analysts are rating ARS Pharmaceuticals Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 15.33, with a change in price of +1.97. Similarly, ARS Pharmaceuticals Inc recorded 1,543,980 in trading volume during the last 100 days, posting a change of +15.60%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for SPRY stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.
SPRY Stock Stochastic Average
As of today, ARS Pharmaceuticals Inc’s raw stochastic average for the last 50 days stands at 20.22%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 21.29%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 9.06% and 5.51%, respectively.
SPRY Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Year to date metric has recorded a gain of 9.53%.However, over the last six months, we can see a weaker performance of 21.67%. Over the last 30 days, the price of SPRY has leaped by -17.00%. And in the last five days, it has fallen by -7.71%.
